Search details
1.
A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation.
J Oncol Pharm Pract
; 30(2): 304-312, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37151021
2.
Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
Antimicrob Agents Chemother
; 66(11): e0083322, 2022 11 15.
Article
in English
| MEDLINE | ID: mdl-36214573
3.
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
J Oncol Pharm Pract
; 28(6): 1357-1362, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-34192963
4.
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.
Am J Transplant
; 21(12): 3894-3906, 2021 12.
Article
in English
| MEDLINE | ID: mdl-33961341
5.
Capsule-related dysphagia and the use of netupitant/palonosetron (Akynzeo™) capsules - A report of two cases and a solution.
J Oncol Pharm Pract
; 27(5): 1284-1286, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33100182
6.
A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners.
J Oncol Pharm Pract
; 26(3_suppl): 22-32, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32268828
7.
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership survey.
J Oncol Pharm Pract
; 26(3_suppl): 11-21, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32268832
8.
International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care.
J Oncol Pharm Pract
; 26(3_suppl): 3-10, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32268831
9.
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 25(7): 1424-1431, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30871976
10.
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(3): 480-487, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30423481
11.
Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections.
Antimicrob Agents Chemother
; 62(10)2018 10.
Article
in English
| MEDLINE | ID: mdl-30012757
12.
Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancer.
Support Care Cancer
; 26(4): 1273-1279, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29090385
13.
Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.
Biol Blood Marrow Transplant
; 22(11): 1915-1925, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27481448
14.
Posaconazole Tablet Formulation at 400 Milligrams Daily Achieves Desired Minimum Serum Concentrations in Adult Patients with a Hematologic Malignancy or Stem Cell Transplant.
Antimicrob Agents Chemother
; 60(11): 6945-6947, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27600035
15.
Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections.
Mycoses
; 59(4): 226-233, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26742659
16.
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.
Biol Blood Marrow Transplant
; 20(5): 600-16, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24462742
17.
Evaluation and implementation of chemotherapy regimen validation in an electronic health record.
J Oncol Pharm Pract
; 20(6): 461-8, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-24500809
18.
Does applying technology throughout the medication use process improve patient safety with antineoplastics?
J Oncol Pharm Pract
; 20(6): 445-60, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-24356802
19.
Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines.
Transplant Cell Ther
; 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38663768
20.
Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.
Biol Blood Marrow Transplant
; 19(4): 509-18, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23419976